Cargando…
Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe Covid-19
• PRES is potentially a complication of severe SARS-CoV-2 infection. • Consider PRES in COVID-19 patients with altered mentation. • Consider tight blood pressure control in ventilated patients with COVID-19. • Hypertensive encephalopathy may prolong ventilator times in COVID-19 patients.
Autores principales: | Kishfy, Louis, Casasola, Marcel, Banankhah, Peymaan, Parvez, Arshi, Jan, Yu Jen, Shenoy, Anant M., Thomson, Carey, AbdelRazek, Mahmoud A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245308/ https://www.ncbi.nlm.nih.gov/pubmed/32474362 http://dx.doi.org/10.1016/j.jns.2020.116943 |
Ejemplares similares
-
Posterior reversible encephalopathy syndrome(PRES)
por: Sudulagunta, Sreenivasa Rao, et al.
Publicado: (2017) -
Posterior Reversible Encephalopathy Syndrome (PRES)
por: Ciozda, William, et al.
Publicado: (2020) -
Daptomycin-Induced Posterior Reversible Encephalopathy Syndrome (PRES)
por: Bitar De Zayas-Enriquez, A., et al.
Publicado: (2019) -
Posterior reversible encephalopathy syndrome (PRES) of the isolated brainstem
por: Hayashi, Yosuke, et al.
Publicado: (2022) -
Nivolumab-Induced PRES (Posterior Reversible Encephalopathy Syndrome)
por: Yashi, Kanica, et al.
Publicado: (2023)